GRP
RAPP

Global Retirement Partners’s Rapport Therapeutics RAPP Stock Holding History

Global Retirement Partners’s Portfolio RAPP Stock Details RAPP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$83 Buy
+2
New +$74 ﹤0.01% 4441
2025
Q4 		$1.21K Sell
40
-5
-11% -$138 ﹤0.01% 3849
2025
Q3 		$1.34K Buy
+45
New +$803 ﹤0.01% 3448

Other funds holding RAPP

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
TGV
TRV GP V Boston, Massachusetts $498M AUM 267.53% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $799M AUM 253.51% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return

Global Retirement Partners's RAPP Position: Q2 2026 in Review

Global Retirement Partners opened a new position in Rapport Therapeutics (RAPP) in Q2 2026: 2 shares worth $83. The stake represents ﹤0.01% of the portfolio and ranks #4441 among its holdings. This is a return to the name: Global Retirement Partners previously reported a position in RAPP as recently as Q4 2025.

Global Retirement Partners first reported a position in RAPP in Q3 2025 and has held it in 3 quarters since. The position peaked at $1.34K in Q3 2025. 160 funds tracked by Wall St. Rank hold RAPP as of Q2 2026.

  • Global Retirement Partners held 2 shares of Rapport Therapeutics worth $83 as of Q2 2026.
  • Rapport Therapeutics was a new Global Retirement Partners position in Q2 2026.
  • Rapport Therapeutics made up ﹤0.01% of Global Retirement Partners's portfolio in Q2 2026, its #4441 holding.
  • Global Retirement Partners first reported a position in Rapport Therapeutics in Q3 2025 and has held it in 3 quarters since.
  • Global Retirement Partners's Rapport Therapeutics position peaked at $1.34K in Q3 2025.
  • 160 funds tracked by Wall St. Rank held Rapport Therapeutics as of Q2 2026.

Based on Global Retirement Partners's 13F filing for Q2 2026, filed 6 Aug 2026.